Covid-19 Impact on Biomarker Market, Global Research Reports 2020-2021
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Biomarker Quarterly Market Size Analysis
- 2.1 Biomarker Business Impact Assessment - COVID-19
- 2.1.1 Global Biomarker Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Biomarker Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Biomarker Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Biomarker Headquarters and Area Served
- 3.3 Date of Key Players Enter into Biomarker Market
- 3.4 Key Players Biomarker Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Biomarker Segments, By Type
- 4.1 Introduction
- 1.4.1 Consumables
- 1.4.2 Service
- 4.2 By Type, Global Biomarker Market Size, 2019-2021
5 Impact of Covid-19 on Biomarker Segments, By Application
- 5.1 Overview
- 5.5.1 Diagnostics Development
- 5.5.2 Drug Discovery and Development
- 5.5.3 Disease-Risk
- 5.2 By Application, Global Biomarker Market Size, 2019-2021
- 5.2.1 By Application, Global Biomarker Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 QIAGEN N.V. (Netherlands)
- 7.1.1 QIAGEN N.V. (Netherlands) Business Overview
- 7.1.2 QIAGEN N.V. (Netherlands) Biomarker Quarterly Revenue, 2020
- 7.1.3 QIAGEN N.V. (Netherlands) Biomarker Product Introduction
- 7.1.4 QIAGEN N.V. (Netherlands) Response to COVID-19 and Related Developments
- 7.2 PerkinElmer, Inc. (U.S.)
- 7.2.1 PerkinElmer, Inc. (U.S.) Business Overview
- 7.2.2 PerkinElmer, Inc. (U.S.) Biomarker Quarterly Revenue, 2020
- 7.2.3 PerkinElmer, Inc. (U.S.) Biomarker Product Introduction
- 7.2.4 PerkinElmer, Inc. (U.S.) Response to COVID-19 and Related Developments
- 7.3 Merck Millipore (U.S.)
- 7.3.1 Merck Millipore (U.S.) Business Overview
- 7.3.2 Merck Millipore (U.S.) Biomarker Quarterly Revenue, 2020
- 7.3.3 Merck Millipore (U.S.) Biomarker Product Introduction
- 7.3.4 Merck Millipore (U.S.) Response to COVID-19 and Related Developments
- 7.4 Bio-Rad Laboratories, Inc. (U.S.)
- 7.4.1 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
- 7.4.2 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Quarterly Revenue, 2020
- 7.4.3 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Product Introduction
- 7.4.4 Bio-Rad Laboratories, Inc. (U.S.) Response to COVID-19 and Related Developments
- 7.5 Enzo Biochem, Inc. (U.S.)
- 7.5.1 Enzo Biochem, Inc. (U.S.) Business Overview
- 7.5.2 Enzo Biochem, Inc. (U.S.) Biomarker Quarterly Revenue, 2020
- 7.5.3 Enzo Biochem, Inc. (U.S.) Biomarker Product Introduction
- 7.5.4 Enzo Biochem, Inc. (U.S.) Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
This report covers market size and forecasts of Biomarker, including the following market information:
Global Biomarker Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Biomarker Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Biomarker Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Biomarker Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Enzo Biochem, Inc. (U.S.), etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Consumables
Service
Based on the Application:
Diagnostics Development
Drug Discovery and Development
Disease-Risk